EUVIMEDEUVIMED entdecken
Crossref

Plant‑derived polydeoxyribonucleotide from Brassica rapa enhances fibroblast and keratinocyte viability and scratch‑wound closure in vitro

Kyeong-Ho Ju, Gyoyoung Lee, Dong-Sung Lee, Jun-Hyeog Jang

Biomedical Reports · 20.11.2026 · 26 (1) · 1-8

DOI: 10.3892/br.2026.2226 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Reports, online erschienen am 20.11.2026. Verfasst von Kyeong-Ho Ju und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polydeoxyribonucleotide (PDRN) is a low-molecular-weight DNA fragment mixture routinely isolated from salmonid tissue and used for regenerative applications. Putative mechanisms for conventional PDRN activity include adenosine A2A receptor signaling and nucleotide salvage. The present study extracted a plant‑derived PDRN from Brassica rapa (BR‑PDRN) using a modified cetyltrimethylammonium bromide (CTAB) protocol followed by controlled sonication. BR‑PDRN had an A260/A280 ratio of 1.95‑2.05 and a fragment distribution of 50‑1,000 bp. These measurements suggest low protein contamination and the intended fragment‑size range; however, they do not establish pharmaceutical‑ or clinical‑grade equivalence as A260/A230, residual CTAB/phenol, endotoxin or other process impurities were not measured. In NIH3T3 fibroblasts, both animal‑derived PDRN and BR‑PDRN (50 µg/ml) increased cell viability, as measured by the 3‑(4,5‑dimethylthiazol‑2‑yl)‑2,5‑diphenyltetrazolium bromide assay, and enhanced scratch wound closure at 48 h compared with the untreated control. BR‑PDRN also increased VEGF , PDGFB , KGF and EGF mRNA. In HaCaT keratinocytes, both preparations increased the CCK‑8 signal and scratch‑wound closure, with BR‑PDRN showing a greater late‑phase CCK‑8 response under the assay conditions. In differentiated 3T3‑L1 adipocytes, both preparations attenuated adiponectin and leptin secretion. Overall, BR‑PDRN exhibits in vitro regenerative activity comparable to an animal‑derived comparator across directly compared assays. Further analytical characterization, dose‑response studies and in vivo wound models should be conducted before clinical translation.

Zitieren

APA

Ju, K., Lee, G., Lee, D., & Jang, J. (2026). Plant‑derived polydeoxyribonucleotide from Brassica rapa enhances fibroblast and keratinocyte viability and scratch‑wound closure in vitro. Biomedical Reports, 26(1), 1-8. https://doi.org/10.3892/br.2026.2226

Vancouver

Ju K, Lee G, Lee D, Jang J. Plant‑derived polydeoxyribonucleotide from Brassica rapa enhances fibroblast and keratinocyte viability and scratch‑wound closure in vitro. Biomedical Reports. 2026;26(1):1-8. doi:10.3892/br.2026.2226

BibTeX
@article{Ju2026,
  author = {Ju, Kyeong-Ho and Lee, Gyoyoung and Lee, Dong-Sung and Jang, Jun-Hyeog},
  title = {Plant‑derived polydeoxyribonucleotide from Brassica rapa enhances fibroblast and keratinocyte viability and scratch‑wound closure in vitro},
  journal = {Biomedical Reports},
  year = {2026},
  volume = {26},
  number = {1},
  pages = {1--8},
  doi = {10.3892/br.2026.2226}
}
Kostenlos starten →